We established LAMP2‐deficient CRC cells (Figure S5C, Supporting Information) and found that the anticancer effects of aripiprazole were significantly attenuated in both HT29 and DLD1 cells with LAMP2 knockout (Figure S5D, Supporting Information). Here, LAMP2 is linked to colorectal carcinoma.